ONDANSETRON (GR38032F) PLUS DEXAMETHASONE - EFFECTIVE ANTIEMETIC PROPHYLAXIS FOR PATIENTS RECEIVING CYTOTOXIC CHEMOTHERAPY

被引：49
|
作者：
SMITH, DB
NEWLANDS, ES
SPRUYT, OW
BEGENT, RHJ
RUSTIN, GJS
MELLOR, B
BAGSHAWE, KD
机构：
[1] Cancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross Hospital, London
来源：
BRITISH JOURNAL OF CANCER | 1990年 / 61卷 / 02期
关键词：
D O I：
10.1038/bjc.1990.62
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：323 / 324
页数：2
相关论文
共 50 条
  • [31] Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer
    Herrstedt, J
    Sigsgaard, T
    Handberg, J
    Schousboe, BMB
    Hansen, M
    Dombernowsky, P
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1690 - 1696
  • [32] Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation
    B Abbott
    C Ippoliti
    J Bruton
    J Neumann
    R Whaley
    R Champlin
    Bone Marrow Transplantation, 1999, 23 : 265 - 269
  • [33] COMPARISON OF DIFFERENT SCHEDULES OF ONDANSETRON (GR 38032F) ADMINISTRATION DURING CISPLATIN-BASED CHEMOTHERAPY - A RANDOMIZED TRIAL
    TSAVARIS, NB
    TSAROUCHANOUTSOU, E
    KARVOUNIS, N
    BACOYANNIS, C
    PAGOU, M
    KOSMIDIS, P
    CHEMOTHERAPY, 1995, 41 (01) : 70 - 76
  • [34] ANTIEMETIC EFFICACY AND PHARMACOKINETIC ANALYSES OF THE SEROTONIN ANTAGONIST ONDANSETRON (GR-38032F) DURING MULTIPLE-DAY CHEMOTHERAPY WITH CISPLATIN PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    LAZARUS, HM
    BRYSON, JC
    LEMON, E
    PRITCHARD, JF
    BLUMER, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (22) : 1776 - 1778
  • [35] ONDANSETRON PLUS METOPIMAZINE COMPARED WITH ONDANSETRON ALONE IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY
    HERRSTEDT, J
    SIGSGAARD, T
    BOESGAARD, M
    JENSEN, TP
    DOMBERNOWSKY, P
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (15): : 1076 - 1080
  • [36] ONDANSETRON - A NEW SAFE AND EFFECTIVE ANTIEMETIC IN PATIENTS RECEIVING HIGH-DOSE MELPHALAN
    VINER, CV
    SELBY, PJ
    ZULIAN, GB
    GORE, ME
    BUTCHER, ME
    WOOTTON, CM
    MCELWAIN, TJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (06) : 449 - 453
  • [37] A PHASE-II STUDY OF ONDANSETRON (GR 38032F) IN NONCISPLATIN CHEMOTHERAPY INDUCED VOMITING RESISTANT TO STANDARD ANTIEMETICS
    EVANS, BD
    DICKSON, D
    MAK, D
    NEEVE, L
    HARVEY, V
    NEW ZEALAND MEDICAL JOURNAL, 1990, 103 (885) : 105 - 105
  • [38] ONDANSETRON (GR-38032F), A COMPETITIVE 5-HT3 ANTAGONIST AS ANTIEMETIC DRUG FOR CYTOSTATIC DRUG-INDUCED NAUSEA AND VOMITING
    SERVE, H
    PERKER, M
    ERTL, A
    REICHOLD, M
    FINK, U
    BERDEL, WE
    ONKOLOGIE, 1990, 13 (05): : 369 - 374
  • [39] THE EFFICACY OF GR38032F, AN ANTAGONIST OF 5-HYDROXYTRYPTAMINE-3 (5-HT3) IN THE PROPHYLAXIS OF CISPLATIN (CDDP)-INDUCED NAUSEA AND VOMITING
    DEHAAN, LD
    DEMULDER, PHM
    BEEX, LVAM
    DEBRUYNE, FMJ
    CHALLONER, T
    DEPAUW, BE
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (08): : 1383 - 1384
  • [40] Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice
    Suthinee Ithimakin
    Kanakorn Runglodvatana
    Akarin Nimmannit
    Charuwan Akewanlop
    Vichien Srimuninnimit
    Narong Keerativitayanan
    Nopadol Soparattanapaisarn
    Apirom Laocharoenkeat
    Supportive Care in Cancer, 2012, 20 : 849 - 855
12345